Trends for the future of the pharmaceutical manufacturing
By Giuliana Miglierini The technological evolution of pharmaceutical manufacturing towards the full implementation of the Industry 4.0 paradigm…
Draft ICH M13A guideline on bioequivalence open for consultation
By Giuliana Miglierini The draft ICH M13A harmonised guideline “Bioequivalence for immediate-release solid oral dosage forms” was endorsed…
Trends in the development of new dosage forms
by Giuliana Miglierini Oral solid dosage (OSD) forms (i.e. capsules and tablets) historically represent the most easy and…
Investing in formulation as success’ factor
by Giuliana Miglierini Formulation is a critical step in the development of new medicinal products, as it directly…